Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

April 2025

Long-term effectiveness and safety of deucravacitinib for psoriasis: a 52-week real-world study of genital, scalp and nail lesions

Clin Exp Dermatol. 2025 Apr 24;50(5):952-959 doi: 10.1093/ced/llae530. PMID: 39657275.

Hagino T,

Saeki H,

Fujimoto E,

Kanda N

Real-world effectiveness and safety data suggest that deucravacitinib is a valuable long-term treatment option for PsO.

Keywords:

Deucravacitinib,
Efficacy,
Real-World,
Safety,
TYK2